Fast determination of free metronidazole in rat plasma and peritoneal fluid using HPLC‐UV method

• Published in: Biomedical chromatography 2023-02, Vol.37 (2), p.e5543-n/a
• Main Authors: Anjos, Michele Vaz, Bergoza, Larissa, Fonseca, Gisele, Possa, Eduarda, Santos, Paulo, Moura e Silva, Sidnei, Tasso, Leandro
• Format: Article
• Language: English
• Subjects: Animals; Anti-Infective Agents; Ascitic Fluid; bioanalytical validation; Chromatography, High Pressure Liquid - methods; HPLC‐UV; Metronidazole; microdialysis; peritoneum; Peritonitis - drug therapy; Rats; Rats, Wistar; Reproducibility of Results
• ISSN: 0269-3879; 1099-0801
• DOI: 10.1002/bmc.5543

Peritonitis refers to the inflammatory reaction of the peritoneum to aggression. In addition, it contributes significantly to sepsis. The presence of free concentrations of antimicrobials above the minimum inhibitory concentration at the site of infection is critical to therapeutic response. Metronidazole (MTZ) is an antimicrobial used to treat peritonitis because of its effectiveness against anaerobic microorganisms. This study investigates free MTZ concentrations in peritoneal microdialysate in Wistar rats. A C18 column (150 × 4.0 mm, 5 μm) was used for the analysis conducted at 40°C under isocratic conditions. The mobile phase consisted of acetonitrile and an aqueous solution of 50‐mM monobasic phosphate buffer and 0.1% triethylamine, with pH 3.0 (10:90, v/v). MTZ calibration was linear in the range of 0.5–30.0 μg/ml. The intra‐ and inter‐day precision was satisfactory with relative standard deviation ≤5.67%. The accuracy ranged from 90.64 to 103.77%, and the lower limit of quantification was 0.5 μg/ml. The developed method was successfully applied in a pilot pharmacokinetic study after MTZ administration (30 mg/kg, intravenously) in rats. The main advantage of the employed method is that it does not require sample processing and protein removal steps. This is the first study to be conducted using MTZ in rats.